Literature DB >> 5496071

Quantitative aspects of the latex-fixation and Whaaler-Rose tests.

A Cats, F Klein.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5496071      PMCID: PMC1010600          DOI: 10.1136/ard.29.6.663

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

1.  Clinical evaluation of the serological tests in rheumatoid arthritis. II. Hospital series of patients with definite rheumatoid arthritis.

Authors:  O WAGER; N RIPATTI; V LAINE; H JULKUNEN; K AHO
Journal:  Acta Rheumatol Scand       Date:  1961

2.  Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis.

Authors:  R C WILLIAMS; H G KUNKEL
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

3.  Complement, complement components, properdin and agglutination promoting factors in rheumatoid arthritis.

Authors:  A B LAURELL; R GRUBB
Journal:  Acta Pathol Microbiol Scand       Date:  1958

4.  Stabilizers and inhibitors in the sensitized sheep-cell agglutination reaction.

Authors:  E C FRANKLIN
Journal:  Arthritis Rheum       Date:  1960-08

5.  Research on the behaviour, nature and meaning of the rheumatoid factor.

Authors:  A ROBECCHI; V DANEO
Journal:  Acta Rheumatol Scand       Date:  1959

6.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

7.  The hemagglutination test for rheumatoid arthritis. III. Clinical evaluation of the sheep erythrocyte agglutination (S.E.A.) test and the gamma globulin (FII) tests.

Authors:  A S JACOBSON; W H KAMMERER; J WOLF; W V EPSTEIN; G HELLER
Journal:  Am J Med       Date:  1956-04       Impact factor: 4.965

8.  FII haemagglutination test for serum antigammaglobulin factors in arthritides sero-positive and sero-negative by other tests.

Authors:  D W Zutshi; C A Reading; W V Epstein; B M Ansell; E J Holborow
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

9.  The induction of a rheumatoid factor-like substance in rabbits.

Authors:  J L ABRUZZO; C L CHRISTIAN
Journal:  J Exp Med       Date:  1961-11-01       Impact factor: 14.307

10.  Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.

Authors:  A Cats; H M Hazevoet
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

View more
  7 in total

1.  A comparison of latex slide tests for rheumatoid factors.

Authors:  D J Lea; D J Ward
Journal:  Ann Rheum Dis       Date:  1972-03       Impact factor: 19.103

2.  Standardisation of serological tests for rheumatoid factor measurement.

Authors:  F Klein; M B Janssens
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

3.  A modified latex-fixation test for the detection of rheumatoid factors.

Authors:  F Klein; W Bronsveld; W Norde; L K Van Romunde; J M Singer
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

4.  Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.

Authors:  H Visser; L B Gelinck; A H Kampfraath; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

5.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Presence of immune complex-like material in sera of patients with paraproteinaemia.

Authors:  F Klein; G J Lafeber; Y E Jongepier-Geerdes; A Cats; R H Kauffmann; J J Michiels
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

7.  Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.

Authors:  W J Habets; D J de Rooij; M H Salden; A P Verhagen; C A van Eekelen; L B van de Putte; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.